Position in ABEO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,598,022
-$481,643 QoQ
Shares Held
803,130
+3.7% QoQ
Ownership
1.41%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABEO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AWM Investment Company, Inc. holds $83,864,916 across 21 Biotechnology names. ABEO ranks #9 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DFTX |
Definium Therapeutics, Inc.
|
1,076,893 | $20,353,277 | |
| 2 | ACOG |
Alpha Cognition Inc.
|
1,672,168 | $9,180,202 | |
| 3 | PVLA |
Palvella Therapeutics, Inc.
|
69,416 | $8,652,704 | |
| 4 | FBRX |
Forte Biosciences, Inc.
|
200,000 | $5,180,000 | |
| 5 | RANI |
Rani Therapeutics Holdings, Inc.
|
6,500,000 | $4,777,500 | |
| 6 | FENC |
Fennec Pharmaceuticals Inc.
|
720,135 | $4,428,830 | |
| 7 | ANRO |
Alto Neuroscience, Inc.
|
170,000 | $3,821,600 | |
| 8 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
100,000 | $3,632,000 |
All Filings in ABEO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,598,022 | 803,130 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,079,665 | 774,130 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,888,160 | 547,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,669,600 | 470,000 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||